Can You Trust Your Real-World Data?

Ken Tarkoff

Ken Tarkoff

March 22, 2021

In my last blog post, I talked about the three key imperatives that the industry faces in realizing the full potential of real-world evidence (RWE) to impact care––promising to dig a little deeper in subsequent blog posts. So let’s start this time with the first imperative: ensuring that the underlying real-world data is capable of answering the questio…

Read this article

Blog Post 2103 Can You Trust


A Real World Dialogue with Dr. Leroy Hood of Institute of Systems Biology

By Thomas Brown, MD

Inaugural Real World Dialogue kicked off with industry heavyweight Dr. Leroy (Lee) Hood sharing his perspective on how real-world evidence will evolve over the years and its potential to end suffering from cancer and other health challenges.



The Innovation Engine That Could: Why It is Important to Carve Out Time to Innovate

By Vinod Subramanian

Syapse made its presence known in the precision medicine and real-world evidence space over a decade ago. In this time, the use and understanding of how real-world data can impact patient care has evolved through technology, research and policy. Staying at the forefront of this work remains critical to our growth. By being a part of the larger digi…



Unlocking the Potential of Real-World Evidence to Improve Cancer Care

By Ken Tarkoff

Three essential challenges we must overcome in order to leverage real-world evidence to impact patient care, and how the ongoing pandemic will continue to shape our approaches to surmounting these challenges.



The FDA’s Recent Guidance on Diversifying Clinical Trials Can Revolutionize Cancer Care for Underrepresented Minorities

By Betty Mbom, PhD

Clinical research serves to grow our understanding of how to best diagnose and treat cancer. For diseases such as testicular cancer and pediatric leukemia, steady increases in survival rates continue due to advancements in clinical research; while diseases such as melanoma and chronic myeloid leukemia are revolutionizing through breakthrough clin…



Reflecting on the Promise of Real-World Data, a Fireside Chat with the FDA

By Antoinette Cummins

Please fill out the form below to view the recording. Syapse hosted its 3rd annual Precision Medicine Council to convene healthcare leaders to discuss applications for real-world insights and common challenges in delivering real-world care. As a part of the council, we invited Dr. Amy Abernethy, Principal Deputy Commissioner of the FDA, to shar…



For People with Cancer — Further Evidence of Worse Outcomes Due to COVID-19

By Thomas Brown, MD

“Delays in screenings, diagnosis and treatment because of the coronavirus pandemic are likely to result in thousands of “excess” deaths from the disease in coming years.” Ned Sharpless, M.D., director of the National Cancer Institute


Load more

Let’s chat

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.